Quarterly report pursuant to sections 13 or 15(d)

Shareholders' Deficit (Details Textual)

v2.4.0.6
Shareholders' Deficit (Details Textual) (USD $)
 9 Months Ended
Mar. 31, 2013
Feb. 02, 2013
Aug. 15, 2012
Jul. 03, 2012
Jun. 30, 2012
Common stock, shares authorized 200,000,000       200,000,000
Common stock, par or stated value per share $ 0.001       $ 0.001
Preferred stock, shares authorized 20,000,000       20,000,000
Preferred stock, par or stated value per share $ 0.001       $ 0.001
Class of warrant or right, number of securities called by warrants or rights   110,000 248,542 1,400,000  
Share-based compensation arrangement by share-based payment award, options, grants in period, gross 9,000,000        
Antriabio Delaware Inc
          
Common stock, shares authorized 90,000,000        
Common stock, par or stated value per share $ 0.00001        
Preferred stock, shares authorized 10,000,000        
Preferred stock, par or stated value per share $ 0.01